Ex-Genzyme chief's $10M gift kicks off MGH cancer center

Biotech pioneer Henri Termeer (photo) can now add a startup to his resume. After recently retiring from Genzyme in the wake of the big Sanofi ($SNY) buyout, Termeer is seeding the Henri and Belinda Termeer Center for Targeted Therapies at Massachusetts General Hospital with a $10 million donation. Report

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.